Alexion Pharmaceuticals Inc (ALXN)

pos +0.00
Today's Range: 185.01 - 190.85 | ALXN Avg Daily Volume: 1,155,400
Last Update: 10/24/14 - 3:59 PM EDT
Volume: 0
YTD Performance: 43.20%
Open: $0.00
Previous Close: $185.92
52 Week Range: $113.14 - $190.85
Oustanding Shares: 197,814,997
Market Cap: 36,777,764,242
6-Month Chart
TheStreet Ratings Grade for ALXN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 10 10
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.43 1.43 1.46 1.46
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 77.47
Price Earnings Comparisons:
ALXN Sector Avg. S&P 500
77.47 93.80 28.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
13.62% 63.06% 173.56%
Revenue 36.80 1.87 0.42
Net Income -0.80 1.61 0.37
EPS -1.40 1.35 0.32
Earnings for ALXN:
Revenue 1.55B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.10 $n.a. $4.56 $5.31
Number of Analysts 4 0 4 4
High Estimate $1.15 $n.a. $4.65 $6.04
Low Estimate $1.04 $n.a. $4.46 $4.38
Prior Year $0.80 $1.41 $2.75 $4.56
Growth Rate (Year over Year) 37.19% n.a.% 65.73% 16.51%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Off the Charts Real Money Pro($)

Updating our current trade ideas.
The stock seems liable to reenter its uptrend, so here's how to play it.
Cautionary tales that the IPO window might be closing at last.

Off the Charts Real Money Pro($)

Intel  breaks above our target on Piper Jaffray upgrade.

Off the Charts Real Money Pro($)

Ford rallies after March auto sales blow past Street view, surpassing our target.

Off the Charts Real Money Pro($)

Alaska Air is trading above all key moving averages with a healthy uptrend since July.
Mar 27, 2014 | 8:14 AM EDT
ALXN estimates were raised through 2016, Credit Suisse said. Expect higher Soliris sales. Neutral rating and new $171 price target.&nbs...
Mar 11, 2014 | 7:49 AM EDT
ALXN raised its number, USB said. Well-positioned with faster ramp of sales in France and opportunity to lever the operating model. $20...
Jan 31, 2014 | 8:21 AM EST
ALXN shares now reaching $145, Jefferies said. Driven by strong Soliris sales and significantly lower tax rates. Hold rating. 
These types of companies are winners today.

Columnist Conversations

GS has cleared the important hurdle on the way up which increases the odds for an eventual rally towards the 1...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher. CLMS was up about ...
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sending the stock up about...
Market posting decent day considering Ebola getting headlines again. Believe investors have learned not to pa...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.